 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs
ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores
Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores
ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores 
              The Nomination and Remuneration and Compensation Committee of the Board of Directors of Vakrangee Ltd at its meeting held on February 16, 2016 has approved and allotted 38875 numbers of Equity Shares having Face Value of Re. 1/- each to the employees of the Company (the Allottees) pursuant to exercise of options under the Company's Employee Stock Option (ESOP) Scheme.
Post allotment of 38875 shares of face value of Re. 1/- each, the Company's issued and paid-up share capital stands increased to 529196170 Equity Shares of face value of Re. 1/- each aggregating to Rs. 52,91,96,170/-.
Shares of Vakrangee Limited was last trading in BSE at Rs.197.8 as compared to the previous close of Rs. 198.25. The total number of shares traded during the day was 740189 in over 6429 trades.
The stock hit an intraday high of Rs. 201 and intraday low of 185.6. The net turnover during the day was Rs. 144145411.